Stock AMIX AUTONOMIX MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
1.37 USD -23.89% Intraday chart for Autonomix Medical, Inc. -39.91% 0.00%
Jun. 03 Autonomix Medical, Inc. Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial CI
May. 31 Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Autonomix Medical, Inc. Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024
Autonomix Enters into Agreement with Noisefigure Research, Inc. to Develop Next Generation of Its Proprietary Microchip
Autonomix Medical, Inc. Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation
Autonomix Appoints Jennifer Cook as Chief Business Officer
Autonomix Medical, Inc. Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
Autonomix Medical, Inc. Secures Principal Investigators and Completes Clinical Training for First Human Study
Autonomix Medical, Inc. Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
Autonomix Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Earnings Overshadow Potential Bond Surge Concerns
Top Premarket Gainers
Autonomix Gets Approval to Start Clinical Trial for Pancreatic Cancer Pain Treatment in Uzbekistan
Autonomix Re-Acquires Sensing Technology from Impulse Medical for $8 Million in Stock
Autonomix Medical, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMIX Stock
  4. News Autonomix Medical, Inc.
  5. Other languages